跳至主要内容
临床试验/JPRN-UMIN000010704
JPRN-UMIN000010704已完成未知

Comparing study of the efficiency and safety in actual use of two kinds of long-acting ESA for renal anemia in hemodialysis patients - Evaluation analysis for the treatment of renal anemia : two new long-acting ESAs randomised comerison trial:EARNEST STUDY

Saiseikai Kumamoto Hospital0 个研究点目标入组 150 人开始时间: 2013年5月13日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Women who are pregnant, breastfeeding, or possibly pregnant Patients who have myocardial infarction,pulmonary embolism or stroke Hypersensitivity to epoetin beta pegol or darbepoetin alfa Patients who have malignant tumor (including hematologic malignancy), severe infection, Hemolytic anemia, hemolytic anemia, or apparent hemorrhagic lesion Patients whose AST or ALT level was 100 IU/L or higher in the latest examination before enrollment Patients who are judged ineligible by the investigator/sub-investigator

研究者

相似试验